BioCryst to Present at JMP Securities Hematology & Oncology Summit
RESEARCH TRIANGLE PARK, N.C., Dec. 05, 2022 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present virtually at the JMP Securities Hematology & Oncology Summit on Wednesday, December 7, 2022, at 11:40 a.m. ET.
Links to the live audio webcast and replay of the presentation may be accessed in the Investors & Media section of BioCryst’s website at http://www.biocryst.com.
About BioCryst Pharmaceuticals
Optimizing the Network and Cloud to Support Digital Transformation
Conference Boxed Lunches - For Diamond, Platinum, Super Pass, Exhibitor/Conference, Speaker, Press Pass Holders
What Do Businesses Need for Effective Communication and Collaboration in Today's Work Environment?